Skip to main content
. 2014 Apr 11;24(7):602–618. doi: 10.1093/glycob/cwu029

Table I.

List of glycopeptides and controls on the defined schistosome microarray

Glycopeptide ID Compound name Printed concentration
1 Agalacto glycopeptide 0.4 mg/mL
2 Agalacto glycopeptide 0.2 mg/mL
3 Asialo glycopeptide 0.4 mg/mL
4 Asialo glycopeptide 0.2 mg/mL
5 Sialo glycopeptide 0.4 mg/mL
6 Sialo glycopeptide 0.2 mg/mL
7 Man3 glycopeptide 0.4 mg/mL
8 Man3 glycopeptide 0.2 mg/mL
9 Core xylose/core fucose glycopeptide 0.4 mg/mL
10 Core xylose/core fucose glycopeptide 0.2 mg/mL
11 Core xylose glycopeptide 0.4 mg/mL
12 Core xylose glycopeptide 0.2 mg/mL
13 LDN glycopeptide 0.4 mg/mL
14 LDN glycopeptide 0.2 mg/mL
15 LDNF glycopeptide 0.4 mg/mL
16 LDNF glycopeptide 0.2 mg/mL
17 Lewis a (Lea) glycan 100 µM
18 Lewis x (LeX) glycan 100 µM
19 PBS
20 Biotin
21 Core fucose (Fuc-Man3) glycopeptide 0.4 mg/mL
22 Core fucose (Fuc-Man3) glycopeptide 0.2 mg/ml
23 Asialo glycan-AEAB 100 μM
24 Man5 glycan-AEAB 100 μM

Structures 1–16 and 21–24 are symmetrical biantennary structures. 21–24 were added on a second iteration of the array. See Figure 1 for the structural details.